KIF12: A Versatile Protein for Drug and Biomarker Research (G113220)

Target Name: KIF12

NCBI ID: G113220

KIF12

KIF12: A Versatile Protein for Drug and Biomarker Research

Kinesin-like protein KIF12 (isoform 1) is a protein that plays a critical role in the transport of various molecules in the cell. It is a member of the Kinesin-like protein family, which includes proteins that are similar to kinesins but have distinct functions. KIF12 is widely expressed in various tissues and cells, including muscle, heart, and brain. Its unique structure and function make it an attractive drug target or biomarker for various diseases.

KIF12 functions as a kinesin-like protein, which means it has the ability to transport proteins across the cell membrane. It does this by interacting with the cytoplasmic side of the protein, which is the side of the cell that is in contact with the environment. KIF12 uses a unique mechanism of interaction to transport proteins across the membrane. It does this by engaging with the protein and then using its own amino acids to shift the protein's position. This allows KIF12 to transport the protein across the membrane and to the opposite side.

KIF12 is a versatile protein that can be used as a drug target or biomarker in various diseases. One of the ways KIF12 can be used as a drug target is by targeting its role in the transport of diseases. For example, KIF12 has been shown to be involved in the transport of certain proteins that are involved in diseases such as cancer, neurodegenerative diseases, and respiratory diseases. By inhibiting the activity of KIF12, researchers can potentially develop new treatments for these diseases.

Another way KIF12 can be used as a biomarker is by monitoring its levels in diseases. KIF12 is often expressed in various tissues and cells, including those that are affected by diseases. By measuring the levels of KIF12 in these tissues, researchers can gain insight into the severity and progression of the disease. This can help doctors to develop more effective treatments and to monitor the effectiveness of existing treatments.

KIF12 is also a potential biomarker for certain diseases. For example, KIF12 has been shown to be involved in the transport of proteins that are involved in neurodegenerative diseases. By measuring the levels of KIF12 in these diseases, researchers can potentially develop new treatments for these conditions. Additionally, KIF12 has also been shown to be involved in the transport of proteins that are involved in respiratory diseases, which can be used as a biomarker for these conditions.

In conclusion, KIF12 is a versatile protein that can be used as a drug target or biomarker in various diseases. Its unique structure and function make it an attractive target for researchers to investigate and develop new treatments. As more research is conducted on KIF12, it is likely that new insights into its role in diseases will be discovered, and it will continue to be a valuable tool for the study of these conditions.

Protein Name: Kinesin Family Member 12

The "KIF12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KIF12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets